1. Home
  2. RDY vs UE Comparison

RDY vs UE Comparison

Compare RDY & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • UE
  • Stock Information
  • Founded
  • RDY 1984
  • UE 2014
  • Country
  • RDY India
  • UE United States
  • Employees
  • RDY N/A
  • UE N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • UE Real Estate
  • Sector
  • RDY Health Care
  • UE Finance
  • Exchange
  • RDY Nasdaq
  • UE Nasdaq
  • Market Cap
  • RDY 2.1B
  • UE 2.2B
  • IPO Year
  • RDY N/A
  • UE N/A
  • Fundamental
  • Price
  • RDY $13.53
  • UE $18.39
  • Analyst Decision
  • RDY Buy
  • UE Hold
  • Analyst Count
  • RDY 1
  • UE 1
  • Target Price
  • RDY $17.00
  • UE $22.00
  • AVG Volume (30 Days)
  • RDY 2.2M
  • UE 1.2M
  • Earning Date
  • RDY 05-16-2025
  • UE 04-30-2025
  • Dividend Yield
  • RDY 0.73%
  • UE 4.10%
  • EPS Growth
  • RDY 2.68
  • UE N/A
  • EPS
  • RDY 0.75
  • UE 0.63
  • Revenue
  • RDY $3,637,607,642.00
  • UE $453,505,000.00
  • Revenue This Year
  • RDY $17.74
  • UE $6.52
  • Revenue Next Year
  • RDY $9.32
  • UE $3.64
  • P/E Ratio
  • RDY $17.82
  • UE $29.06
  • Revenue Growth
  • RDY 14.74
  • UE 8.73
  • 52 Week Low
  • RDY $12.26
  • UE $15.66
  • 52 Week High
  • RDY $16.89
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • RDY 52.27
  • UE 51.78
  • Support Level
  • RDY $13.17
  • UE $18.23
  • Resistance Level
  • RDY $14.06
  • UE $18.62
  • Average True Range (ATR)
  • RDY 0.20
  • UE 0.34
  • MACD
  • RDY -0.05
  • UE 0.07
  • Stochastic Oscillator
  • RDY 54.44
  • UE 71.72

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: